Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
3h
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha ...
12h
What You Should Know About Ovarian Cancer Vaccines
Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump taps Carr to lead FCC
Visits Amazon rainforest
Calls for Gaza attacks probe
Linked to E. coli outbreak
Sells for record price
Neo-Nazi march in Ohio
Settles defamation lawsuit
Israeli strikes in Gaza
Flash bombs target home
Lays off over 400 workers
Governors Awards 2024
SpaceX launches ‘Optus-X’
To celebrate NBA title at WH
NBA fines Bucks coach
1st Black MSU president dies
Gymnastics coach dies at 82
Attends UFC fight in NYC
Fight draws 60M households
Quakes hit Inland Empire
Settle suit over TV rights
Severe mpox strain in CA
Jones retains UFC title
RU targets UKR power grid
Wins Miss Universe 2024
Fire threat in Northeast
Biden OKs use of US missiles
Retires from NFL at 27
Turns over some assets
Tapped as energy secretary
98th World Cup win
California to rename places
USPS to release stamp
Feedback